This functionality is implemented using Javascript. It cannot work without it, etc...

We are loading the information...

Skip to main content

Medical Policies

Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.

Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.

ID Title Last Review Next Review Description Access
11.003.014 Noninvasive Fetal Rhd Genotyping Using Cell-Free Fetal Dna Sep 12, 2024 Sep 20, 2025 Rhesus d (rhd)-negative women who are exposed to rhd-positive red blood cells can develop anti-rhd... View
11.003.015 Gene Expression Profile Testing And Circulating Tumor Dna Testing For Predicting Recurrence In Colon Cancer Sep 18, 2024 Sep 20, 2025 Gene expression profile (gep) and circulating tumor dna (ctdna) tests have been developed for use as... View
11.003.016 Genetic Testing For Pten Hamartoma Tumor Syndrome Mar 10, 2025 Mar 20, 2026 The pten hamartoma tumor syndrome (phts) includes several syndromes with heterogeneous clinical symptoms,... View
11.003.017 Genetic Testing For Hereditary Hearing Loss May 12, 2024 May 20, 2025 Hearing loss is a common birth defect. approximately 1 in 500 newborns in developed countries is affected by... View
11.003.018 Chromosomal Microarray Testing For The Evaluation Of Pregnancy Loss Sep 19, 2024 Sep 20, 2025 Chromosomal microarray (cma) testing of fetal tissue or placental tissue derived from the fetal genotype has... View
11.003.020 Genetic Testing For Lactase Insufficiency Jul 17, 2024 Policy Archived Genetic testing of adults with suspected lactase insufficiency is proposed as an alternative to current... View
11.003.021 Gene Expression Testing In The Evaluation Of Patients With Stable Ischemic Heart Disease Apr 20, 2021 Policy Archived Expression levels of various genes in circulating white blood cells or whole blood samples have been reported... View
11.003.022 Genetic Testing For Li-Fraumeni Syndrome Aug 20, 2024 Aug 20, 2025 Li-fraumeni syndrome (lfs) is a cancer predisposition syndrome associated with the development of several... View
11.003.023 General Approach To Evaluating The Utility Of Genetic Panels Jan 21, 2025 Jan 20, 2026 Genetic panel testing offers potential advantages and disadvantages compared with direct sequence analysis.... View
11.003.025 Genetic Testing For Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, And Congenital Anomalies Nov 22, 2024 Nov 20, 2025 Chromosomal microarray (cma) testing has been proposed for the detection of genetic imbalances in infants or... View
11.003.026 Comprehensive Genomic Profiling for Selecting Targeted Cancer Therapies Mar 20, 2025 Nov 20, 2025 Comprehensive genomic profiling offers the potential to evaluate a large number of genetic markers at a... View
11.003.027 Gene Variants Associated With Breast Cancer In Individuals At High Breast Cancer Risk. Sep 12, 2024 Sep 20, 2025 It is estimated that 3% to 5% of women presenting for assessment for hereditary breast/ovarian cancer risk... View
11.003.028 Genetic Testing For Lynch Syndrome And Other Inherited Colon Cancer Syndromes Dec 05, 2024 Oct 20, 2025 Genetic testing is available for both those with and those at risk for various types of hereditary cancer.... View
11.003.029 Epithelial Cell Cytology In Breast Cancer Risk Assesment And High-Risk Patient Management (Ductal Labage And Suction Collection Systems) May 20, 2019 Policy Archived In summary, the available literature regarding ductal lavage and suction collection systems for breast cancer... View
11.003.030 Genetic Testing For Brca1 Or Brca2 For Hereditary Breast/Ovarian Cancer Syndrome And Other High-Risk Cancers Feb 10, 2025 Sep 20, 2025 Hereditary breast and ovarian cancer syndrome describe the familial cancer syndromes related to variants in... View
11.003.031 Genetic Testing For Hereditary Hemochromatosis Jul 10, 2024 Policy Archived Hereditary hemochromatosis (hh), a common genetic disorder of iron metabolism, can lead to inappropriate iron... View
11.003.032 Analysis Of Human Dna In Stool Samples As A Technique For Colorectal Cancer Screening Jan 20, 2025 Jan 20, 2026 Of safety and effectiveness data (ssed): cologuard. august 2014. accessed oct 21,... View
11.003.033 Análisis de los patrones proteómicos séricos para identificar el cáncer de ovari May 12, 2016 Policy Archived ... View
11.003.034 Genetic And Protein Biomarkers For The Diagnosis And Cancer Risk Assessment Of Prostate Cancer Dec 20, 2024 Dec 20, 2025 Various genetic and protein biomarkers are associated with prostate cancer. these tests have the potential to... View
11.003.035 Assays Of Genetic Expression In Tumor Tissue As A Technique To Determine Prognosis In Patients With Breast Cancer Dec 06, 2024 Dec 20, 2025 Laboratory tests have been developed to detect the expression, via messenger rna, of different genes in... View

Want to be up to date on topics like health, trending news, useful tips, lifestyles and more?

Subscribe to our blog and don't miss out on anything!

Subscribe to the blog

We want to personalize the content according to your preferences

Please select one or more categories to continue

Thanks for subscribing!

You will receive information of interest in your email.

787-277-6653 787-474-6326